Knowledge Hub · miniGITA Single Radio-TLC
A radiopharmacy releases a labelled batch on a single binary decision — radiochemical purity above the Eur.Ph. or USP <823> monograph threshold, or it doesn't go. This page unpacks why thin-layer chromatography is the right tool to produce that number, where a NaI(Tl) single-detector instrument fits the daily release workflow, and what the 21 CFR Part 11 audit trail captures on every release.
Why this matters
Radio-TLC vs radio-HPLC
Radio-HPLC separates impurities chromatographically and is the right tool for impurity quantitation and method-development work. Radio-TLC is faster (2–3 min per release), cheaper to run, and produces a single number — %RCP — that gates the patient injection. For the daily hot-lab release of Tc-99m, F-18, Ga-68 and Lu-177 batches, the %RCP-against-monograph release model is what Eur.Ph., USP and IAEA endorse. HPLC stays in the QC programme for monthly cross-check and for chemical-purity work.
Based on: Eur.Ph. Radiopharmaceutical Preparations general monograph 0125; USP <823> — Positron Emission Tomography Drugs.
Read source ↗NaI(Tl) single-detector design
A NaI(Tl) scintillation head spans 80 keV (Tc-99m Lα X-ray) to 1.27 MeV (Cu-64 high-energy line) with good detection efficiency. The 140 keV Tc-99m photopeak, the 113 / 208 keV Lu-177 doublet, the 364 keV I-131 line and the 511 keV F-18 / Ga-68 / Cu-64 annihilation peak are all detected on the same hardware — what changes between methods is the energy window and the regression, not the detector. One calibration, every isotope.
Based on: IAEA Quality Assurance for Radioactivity Measurement in Nuclear Medicine; ICRP Publication 107 — Nuclear Decay Data for Dosimetric Calculations.
Read source ↗Eur.Ph. / USP <823> %RCP
Eur.Ph. monographs and USP <823> define per-radiopharmaceutical thresholds — typically %RCP ≥ 95 % for Tc-99m kit products, ≥ 95 % for FDG, ≥ 95 % for Ga-68 DOTA-peptides, ≥ 99 % for Lu-177 DOTA-peptides. The release decision is binary against the threshold. The QC-software calculation, the threshold, the operator signature and the timestamp constitute the release record — the document the AERB inspector reads.
Based on: Eur.Ph. 0125 Radiopharmaceutical Preparations; USP <823>; AERB Safety Code for Nuclear Medicine Facility.
Read source ↗Hot-lab workflow fit
Workflow: labelling vial → withdraw a few microlitres → spot onto TLC / ITLC strip → develop in solvent → dry → scan in the radio-TLC → release decision against the monograph → assay activity in the dose calibrator → unit-dose dispense. The radio-TLC owns the purity gate. The dose calibrator owns the activity gate. Both data points sit on the batch record before the dose leaves the hot lab.
Based on: IAEA Operational Guidance on Hospital Radiopharmacy; EANM hospital-radiopharmacy practice guidelines.
Read source ↗21 CFR Part 11 audit
The instrument software ships 21 CFR Part 11 compliant — electronic-record retention, electronic-signature non-repudiation, audit trail of method changes and overrides. AERB inspection asks for the chain: who released which batch against which monograph, when. The instrument software produces that chain automatically; no parallel paper log to maintain.
Based on: US FDA 21 CFR Part 11 — Electronic Records, Electronic Signatures; AERB inspection-readiness expectations for hospital radiopharmacy.
Read source ↗AERB hot-lab QC
The radio-TLC scanner manipulates licensed-isotope activity in microlitre quantities. No separate AERB licence is needed for the instrument itself — it operates inside the radiopharmacy licence that covers Tc-99m / F-18 / Ga-68 / Lu-177 handling. Site PQ + IQ / OQ during install satisfies the AERB inspector at first inspection; per-release records satisfy at every subsequent visit.
Based on: AERB Safety Code for Nuclear Medicine Facility — radiopharmacy QC equipment expectations.
Read source ↗Pharmacopeial, AERB and IAEA documents that anchor the radiochemical-purity release workflow.
US Pharmacopeia general chapter defining radiochemical-purity test methods and per-monograph release thresholds.
European Pharmacopoeia general + per-isotope monographs defining radiochemical-purity thresholds for clinical radiopharmaceuticals.
Indian regulatory framework for nuclear-medicine facility licensing including hot-lab QC expectations.
IAEA framework for hospital-radiopharmacy operational radiation protection and QC.
Where next